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patients with persistent type II leaks and sac enlargement har-
bor unsuspected type I or type III leaks. Thus, they recommend
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This article questions our current assumptions concerning the
treatment outcomes of type II endoleaks. While it is generally
acknowledged that these leaks occur frequently and are usually
merely annoying, the results of treating more pernicious type II
endoleaks that are accompanied by sac enlargement are largely
unknown. These latter leaks, while rare, are often complicated,
involving several sets of lumbar arteries, the inferior mesenteric
artery, and extensive collateral networks. It is not surprising that
simple embolization of the lumber, mesenteric, or internal iliac
branches would not control these leaks. In fact, several groups have
pointed this out, recommending translumbar approaches with
coils and glue, and insisting on complete obliteration of the leak
“nidus” within the sac.
Until now, many of us probably thought that this direct sac
approach would be definitive and long-lasting. This article
questions that assumption by indicating that 72% of patients
who underwent treatment had not only persistent leaks, but
more important, continuing sac growth. But probably the au-
thors’ most important point is that the aneurysms of somengiography on all patients with any type of leak and an enlarg-
ng aneurysm. This advice is reasonable and widely accepted.
The authors recognize several weaknesses in their evaluation
f their data. The most glaring is the inability of the authors to
valuate almost 60% of the preoperative computed tomography
cans, relying on the initial radiologic report, a practice fraught
ith inaccuracies. While this damages the calculations of the pre-
perative slope value, it does not change the fact that the leaks
ersisted or recurred despite treatment. In addition, the reader has
o accept the complete abolition of the endoleak since no images
ere provided. Furthermore, the interventional radiologist who
erformed the procedures favored translumbar sac embolization
ver other modalities.
As any good article should, the report raises questions: Should
here be a size threshold reached before treatment of type II leaks?
oes sac enlargement of 5 mm in a 5-cm aneurysm have the same
rognosis as 5 mm growth in an 8-cm aneurysm? Should we perform
ngiography on patients with a long infrarenal neck, small aneurysm,
nd 5-mm sac increase? What is the best method for imaging and
reating these leaks? Hopefully, this article will stimulate other groups
o look at their data and help answer these questions.
